Shares of the life sciences SPAC are expected to begin trading today on the NYSE under “CHFW.U”. View notice.
Related Posts
Coliseum Acquisition Sponsor Sells Interest to New Management
The sale covered 2,625,000 Class B shares and 2,257,500 warrants for an aggregate purchase price of $1 plus the acquirer’s agreement to advance funds to the SPAC for its deadline extension through June 2024, if necessary.
Embrace Change Acquisition Shareholders Vote to Remove Restriction on China Targets
The SPAC said 824,682 shares were redeemed, or about 10% of shares outstanding.
VIDA FLaSH Trims Deal Size 14% Ahead of $150M IPO
The new SPAC plans to target the healthcare sector in the United States.
Health Assurance Stock and Warrants to Begin Separate Trading
Shares and warrants may trade separately beginning Jan. 4.